Cargando…
Screening for TP53 mutations in patients and tumours from 109 Swedish breast cancer families.
To estimate the prevalence of TP53 mutations in familial breast cancer, constant denaturant gel electrophoresis (CDGE) was used to screen exons 5-8 of the TP53 gene for germline mutations. Genomic DNA from 128 breast cancer patients belonging to 109 families with familial cancer were screened. No ge...
Autores principales: | Zelada-Hedman, M., Børresen-Dale, A. L., Claro, A., Chen, J., Skoog, L., Lindblom, A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1997
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2222784/ https://www.ncbi.nlm.nih.gov/pubmed/9099970 |
Ejemplares similares
-
A segregation analysis of testicular cancer based on Norwegian and Swedish families.
por: Heimdal, K., et al.
Publicado: (1997) -
Analysis of p53, p16MTS, p21WAF1 and H-ras in archived bladder tumours from workers exposed to aromatic amines.
por: Sørlie, T., et al.
Publicado: (1998) -
Studies of TP53 haplotypes in relation to LOH and TP53 mutations in breast cancer patients
por: Langerød, A, et al.
Publicado: (2000) -
Whole-body MRI within a surveillance program for carriers with clinically actionable germline TP53 variants - the Swedish constitutional TP53 study SWEP53
por: Omran, Meis, et al.
Publicado: (2020) -
TGFBR1 variants TGFBR1(*)6A and Int7G24A are not associated with an increased familial colorectal cancer risk
por: Skoglund Lundin, J, et al.
Publicado: (2009)